Charcot-Marie-Tooth neuropathy X-linked recessive 5 (often shortened to CMTX5) is a very rare inherited nerve disease that mainly damages the long nerves in the arms and legs and also affects hearing and vision. It is called “X-linked recessive” because the faulty gene sits on the X chromosome, and the disease almost always appears in boys and men, while women are usually healthy carriers. In this condition, children usually start life looking normal, but over childhood they slowly develop weakness and wasting of the muscles of the feet and legs, problems with walking, severe hearing loss, and later damage to the optic nerve that carries visual information from the eye to the brain. monarchinitiative.org+2malacards.org+2
Charcot-Marie-Tooth neuropathy X-linked recessive 5 (CMTX5) is a very rare inherited nerve disease. It is caused by loss-of-function changes (mutations) in a gene called PRPS1 on the X chromosome. This gene helps make an enzyme needed to produce important “building blocks” (nucleotides) for cells, including nerve cells. When PRPS1 does not work well, the long nerves in the arms and legs, as well as nerves for hearing and vision, slowly become damaged. People with CMTX5 usually have a combination of peripheral neuropathy (weakness and numbness of hands and feet), early hearing loss, and optic nerve damage (optic atrophy) that can reduce vision.NCBI+2ZFIN+2
Because CMTX5 is X-linked recessive, it mainly affects males, while females in the family may carry the gene and have mild or no symptoms. The disease usually starts in childhood or teenage years and progresses slowly. At this time, there is no cure or “disease-modifying” drug for any Charcot-Marie-Tooth disease, including CMTX5. Treatment focuses on supporting the person, protecting function, and treating symptoms with a multidiscipli
This disease is caused by a harmful change (mutation) in a gene called PRPS1 on the X chromosome. The PRPS1 gene gives instructions to make an enzyme (PRS-I) that helps the body build important molecules called nucleotides, which are needed for energy and for the normal work of many cells, including nerve cells and cells in the inner ear and optic nerve. When PRPS1 does not work properly, the long nerves in the limbs, the hearing nerve, and the optic nerve slowly become sick and cannot send signals well, which explains the combination of weakness, hearing loss, and vision problems. ScienceDirect+2malacards.org+2
CMTX5 belongs to the large family of Charcot-Marie-Tooth diseases (CMT), which are hereditary neuropathies that cause slowly progressive weakness, muscle wasting, and loss of feeling in the hands and feet. CMTX5 is one of the rarest X-linked forms, and its point prevalence is estimated to be much less than 1 in a million people worldwide. It usually begins in infancy or early childhood, and symptoms then slowly worsen over many years. malacards.org+2Global Genes+2
Other Names
CMTX5 is known in the medical literature by many other names. These different names all describe the same or very closely related condition:
One common name is “Charcot-Marie-Tooth disease X-linked recessive 5,” which stresses that this disease is one of several numbered X-linked types of Charcot-Marie-Tooth disease and that it follows an X-linked recessive inheritance pattern. malacards.org+1
Another widely used name is “Charcot-Marie-Tooth neuropathy X-linked recessive 5,” which focuses on the neuropathy (nerve damage) part and again shows that it is the fifth X-linked recessive subtype described. malacards.org+1
The name “CMTX5” or “CMT5X” is a shortened code often used in research papers and gene panels; “CMT” stands for Charcot-Marie-Tooth, “X” for X-linked, and “5” for type 5. malacards.org+1
Several names describe the three main problems seen in this disease. “Optic atrophy, polyneuropathy, and deafness” and “optic atrophy, neural deafness, and distal neurogenic amyotrophy” both highlight damage to the optic nerve (optic atrophy), to the long peripheral nerves (polyneuropathy), and to the hearing nerve, which together give the typical picture of weak distal muscles, hearing loss, and vision loss. NCBI+2malacards.org+2
The term “Rosenberg-Chutorian syndrome” is a historical name given after doctors who first described families with this combination of optic atrophy, deafness, and peripheral neuropathy, and today we know that many of these families carry PRPS1 mutations and belong within the CMTX5 spectrum. malacards.org+2PMC+2
Other closely related PRPS1-related names include “PRPS1-related Charcot-Marie-Tooth neuropathy X type 5” and conditions on the same disease spectrum, such as “Arts syndrome” and “DFN2 (prelingual nonsyndromic sensorineural deafness),” which share the same gene but show different severity and combinations of neuropathy, hearing loss, and brain symptoms. malacards.org+2PMC+2
Types
Doctors do not formally divide CMTX5 into many separate types, but they do recognize several clinical patterns that can be seen along a spectrum of PRPS1-related disease. These patterns help to understand how the same gene problem can present differently in different people and families. ScienceDirect+2malacards.org+2
One common pattern is the “classic CMTX5 triad,” where a boy develops progressive weakness and wasting of the distal leg and arm muscles, profound sensorineural hearing loss from early life, and progressive damage to the optic nerve leading to loss of central vision. This classic picture is what many experts mean when they use the name CMTX5. ScienceDirect+2malacards.org+2
A second pattern is “CMTX5 without optic atrophy,” where patients have the typical peripheral neuropathy and early severe hearing loss, but their optic nerves remain relatively preserved, at least for many years. This milder eye involvement has been reported in some families and shows that optic nerve damage, although common, is not absolutely required for the diagnosis. PMC+2JCN+2
Another pattern is “CMTX5 with cerebellar features or ataxia,” where, in addition to neuropathy, hearing loss, and optic atrophy, some patients develop problems with balance, coordination, and unsteady walking because of involvement of brain structures such as the cerebellum. These cases support the idea that PRPS1-related disease can sometimes affect central nervous system regions as well as peripheral nerves. PMC+2ScienceDirect+2
A broader way of thinking about types is to place CMTX5 on the “PRPS1 disease continuum,” which runs from isolated early-onset deafness (DFN2), through CMTX5 with deafness and optic neuropathy, to Arts syndrome, which includes severe neurologic symptoms and frequent infections. In this view, CMTX5 is an intermediate phenotype where nerve and sense organ damage is serious but life-threatening brain involvement is less extreme than in classical Arts syndrome. ScienceDirect+2malacards.org+2
Causes
CMTX5 has one main root cause, but many related factors that explain how and why it appears in a family. Below each “cause” is explained as a simple idea contributing to the disease.
-
PRPS1 loss-of-function mutation – The central cause is a damaging change in the PRPS1 gene that reduces or destroys the activity of the PRS-I enzyme. Without enough PRS-I, nerve cells cannot make certain nucleotides properly, and over time they become weak and die, especially long peripheral nerves, the auditory nerve, and the optic nerve. ScienceDirect+2malacards.org+2
-
X-linked recessive inheritance – Because PRPS1 lies on the X chromosome, boys who inherit a mutated copy from their mother have no second healthy X to compensate, so they develop the full disease. Girls usually carry one normal and one mutated copy and often show mild or no symptoms, which explains the strong male predominance. NCBI+2monarchinitiative.org+2
-
Missense mutations in critical PRPS1 regions – Many reported families have “missense” changes, where just one amino acid in the PRS-I protein is replaced by another, especially in regions important for enzyme activity or dimer formation; this subtle change is enough to reduce enzyme function and cause neuropathy, hearing loss, and optic neuropathy. ScienceDirect+1
-
Other severe PRPS1 variants (nonsense, frameshift, splice) – Some patients have more disruptive PRPS1 mutations, such as a premature stop codon or a frame shift, which shorten the protein or prevent it from being made correctly, leading to even lower enzyme activity and often more severe disease. malacards.org+2PMC+2
-
Reduced nucleotide production in neurons – PRS-I is needed to produce phosphoribosyl pyrophosphate (PRPP), a key building block for purine and pyrimidine nucleotides; when PRPP is low, nerve cells cannot easily maintain their long axons, repair damage, or support myelin, making them vulnerable to degeneration. ScienceDirect+2PMC+2
-
High vulnerability of long peripheral nerves – The very long motor and sensory nerves that reach the feet and hands need constant energy and transport; with reduced PRPS1 activity, these long nerves are especially fragile, so they are often the first to show weakness and numbness. malacards.org+2Dove Medical Press+2
-
Selective vulnerability of auditory pathways – The inner ear hair cells and auditory nerve fibers have high metabolic needs; when nucleotide supply is impaired, these cells may fail early, explaining the profound prelingual sensorineural hearing loss seen in CMTX5. ScienceDirect+2PubMed+2
-
Selective vulnerability of the optic nerve – The optic nerve is made of long, thin nerve fibers that transmit visual information nonstop; this tissue is sensitive to mitochondrial and metabolic stress, so reduced PRPS1 activity can gradually damage these fibers, causing optic neuropathy and optic atrophy. malacards.org+2Global Genes+2
-
Residual PRPS1 activity level – Different mutations leave different amounts of enzyme activity; moderate loss of activity tends to cause the CMTX5 picture, while very low residual function can result in Arts syndrome, and higher residual function may produce isolated deafness, showing that the degree of enzyme impairment shapes the clinical phenotype. ScienceDirect+2PMC+2
-
De novo mutations – In some families a PRPS1 mutation may appear for the first time in a child (de novo), without any history of similar disease, because a copying error occurred in the sperm or egg; this new mutation then behaves like any X-linked recessive variant. malacards.org+2Dove Medical Press+2
-
Carrier mothers with skewed X-inactivation – Female carriers usually stay healthy because half their cells use the normal X; however, if X-inactivation is skewed and more cells use the mutant X, a carrier woman can show hearing loss or mild neuropathy, acting functionally like a partial cause of disease expression in females. malacards.org+2monarchinitiative.org+2
-
Family history of X-linked neuropathy or deafness – The presence of similar problems (especially in males on the maternal side) increases the chance that a PRPS1 mutation is present and is the underlying cause, even before genetic testing confirms it. malacards.org+2Global Genes+2
-
Shared pathways with other PRPS1 disorders – PRPS1 mutations causing gout, DFN2, CMTX5, and Arts syndrome act through overlapping metabolic pathways; although they produce different diseases, the common mechanism is impaired control of PRPP and nucleotide levels, which is a broad biochemical cause in all these conditions. ScienceDirect+2malacards.org+2
-
Growth and lengthening of nerves in childhood – CMTX5 often starts in infancy or early childhood, when nerves are still growing longer; during this period, reduced nucleotide supply and impaired repair may have the biggest impact, triggering early onset of weakness and sensory loss. malacards.org+2Global Genes+2
-
Metabolic stress and energy demand – Nerve cells and sensory pathways have constant high energy demand; when nucleotide metabolism is disturbed, these cells may fail under metabolic stress, especially during illness or fever, which can worsen neuropathy or hearing and vision loss. ScienceDirect+2malacards.org+2
-
Possible interaction with other genetic variants – In some individuals, additional genetic changes in other nerve or mitochondrial genes may modify the severity of CMTX5, acting as background causes that make symptoms better or worse, although this area is still under research. malacards.org+2Dove Medical Press+2
-
Lack of compensating PRPS isoforms in key tissues – Other forms of the PRPS enzyme (PRS-II) may not fully compensate in certain neurons, especially in the optic nerve and cochlea, so PRPS1 loss has a larger impact there, which is an anatomical cause of the specific organ involvement. ScienceDirect+2PMC+2
-
Progressive axonal degeneration – Over time, the combination of metabolic disturbance and poor repair causes slow dying back of the longest nerve fibers (axons), a pathologic cause that explains the chronic progressive nature of the neuropathy. malacards.org+2Dove Medical Press+2
-
Myelin changes in some patients – Some studies suggest that, in addition to axonal damage, there may be secondary changes in the myelin sheath that insulates nerves, which can further slow conduction and contribute to weakness and sensory loss. malacards.org+2Dove Medical Press+2
-
Ultra-rare nature and diagnostic delay – Finally, because CMTX5 is extremely rare, many families do not receive a correct diagnosis for years, and during this time there is no targeted management; this delay is not a biological cause but does cause more disability, because supportive care and rehabilitation are not started early. malacards.org+2Global Genes+2
Symptoms
-
Progressive distal muscle weakness in the legs – Children with CMTX5 often first show weakness in the muscles of the lower legs and feet, which may appear as difficulty running, trouble climbing stairs, or tiring easily; this weakness slowly worsens over years as the peripheral nerves become more damaged. malacards.org+2Global Genes+2
-
Muscle wasting (atrophy) of the feet and lower legs – Over time, the muscles that are not properly activated by their nerves shrink and become thin, giving a “stork-leg” appearance with skinny calves and bony feet, which is very typical of hereditary motor neuropathies like CMTX5. malacards.org+2Dove Medical Press+2
-
Foot drop and gait disturbance – Because of weakness of the muscles that lift the foot, the toes may drag on the ground (foot drop), and the child may walk with a high-stepping gait or trip easily; this gait disturbance is often one of the first clear signs noticed by families. malacards.org+2Global Genes+2
-
Weakness in the hands and distal arms – As the disease progresses, similar weakness and wasting can appear in the small muscles of the hands, making it harder to grip objects, button clothes, or perform fine motor tasks. malacards.org+2Dove Medical Press+2
-
Loss of sensation in the feet and hands – Many patients develop reduced feeling for vibration, temperature, or pain in a “glove and stocking” pattern affecting the most distant parts of the limbs, which can lead to injuries, calluses, or unnoticed wounds. malacards.org+2Dove Medical Press+2
-
Absent or reduced tendon reflexes – On neurological examination, the usual knee and ankle reflexes are often weak or absent because the sensory and motor limbs of the reflex arc are damaged; this is a standard finding in CMT and helps doctors recognize neuropathy. malacards.org+2Dove Medical Press+2
-
High-arched feet and other foot deformities – Over time, imbalanced muscle pull can lead to pes cavus (high-arched feet) and sometimes claw toes, which may cause pain, calluses, and difficulty finding proper shoes. malacards.org+2Dove Medical Press+2
-
Profound, early-onset sensorineural hearing loss – A hallmark of CMTX5 is severe bilateral hearing loss that begins before speech develops (prelingual), because the inner ear and auditory nerve are affected; many children need strong hearing aids or cochlear implants for communication. ScienceDirect+2malacards.org+2
-
Progressive optic neuropathy and visual loss – Many patients develop optic neuropathy, where the optic nerve slowly loses fibers; this appears as reduced visual acuity, problems with color vision, and pale optic discs on eye examination, which may progress to significant visual disability. malacards.org+2chorobyrzadkie.gov.pl+2
-
Balance problems and unsteady gait – Loss of sensation from the feet and possible cerebellar involvement can cause poor balance, making it hard to walk in the dark or on uneven ground, and some patients show ataxia (uncoordinated movements). PMC+2Mendelian+2
-
Motor developmental delay – Because weakness and neuropathy start in early life, some children with CMTX5 may sit, crawl, or walk later than their peers, and they may be slower in activities that require leg strength or coordination. Global Genes+2Mendelian+2
-
Fatigue and reduced exercise tolerance – Daily activities that require walking or standing for long periods can be tiring, and children may avoid sports or play because their legs tire quickly or become painful. malacards.org+2Wiley Online Library+2
-
Orthopedic complications such as scoliosis – Some patients develop curvature of the spine (scoliosis) or other skeletal changes due to muscle imbalance and chronic weakness, which may further affect posture and breathing mechanics. Mendelian+2Dove Medical Press+2
-
Occasional cognitive or central nervous system features – In a few reported PRPS1 cases on the same spectrum, there can be learning difficulties, ataxia, or mild intellectual disability, showing that brain involvement is possible, although this is more typical of severe Arts-spectrum disease than of classic CMTX5. ScienceDirect+2PMC+2
-
Increased risk of falls and injuries – Because of weakness, poor balance, and lack of feeling, people with CMTX5 are at higher risk of tripping, sprains, and cuts, especially in the feet and ankles, and need to be careful about foot care and safe environments. malacards.org+2malacards.org+2
Diagnostic Tests
Physical Examination
In real life, doctors combine the story, physical exam, nerve tests, eye and ear tests, and genetic testing to diagnose CMTX5 and rule out other similar disorders.
1. Complete neurological examination – The doctor carefully checks muscle strength, tone, reflexes, and sensation in all four limbs; the typical pattern of distal weakness and wasting, reduced reflexes, and sensory loss suggests a length-dependent peripheral neuropathy such as CMT, and when combined with hearing and vision problems, raises strong suspicion for CMTX5. malacards.org+2Wiley Online Library+2
2. Gait and posture assessment – Observation of how the child walks, runs, and stands helps reveal foot drop, high-stepping gait, poor balance, or need for support; these physical signs support the diagnosis of a chronic neuropathy with motor involvement. malacards.org+2Wiley Online Library+2
3. Inspection of feet, hands, and spine – The doctor looks for pes cavus, claw toes, thin lower legs, and hand muscle wasting, as well as possible scoliosis; these structural changes are common in long-standing CMT and help distinguish hereditary neuropathies from acute nerve problems. malacards.org+2Dove Medical Press+2
4. Basic hearing screening at the bedside – Simple tests, such as whispering numbers or using a tuning fork, can show that the patient has significant hearing loss, which then leads to formal audiology testing; early detection of this combination of severe hearing loss and neuropathy is key for suspecting CMTX5. ScienceDirect+2Global Genes+2
5. Eye and optic nerve examination – Using an ophthalmoscope or slit lamp, the eye doctor checks the optic discs; pale optic nerves and reduced visual acuity, together with neuropathy and deafness, strongly point toward CMTX5 rather than other isolated eye diseases. malacards.org+2chorobyrzadkie.gov.pl+2
Manual Clinical Tests
6. Manual muscle testing (MMT) – The neurologist grades strength in many muscle groups using simple resistance movements; the pattern of weakness mainly in distal muscles of the ankles, feet, and later the hands fits a chronic hereditary neuropathy like CMTX5. malacards.org+2Dove Medical Press+2
7. Detailed sensory testing – Using tools like cotton, pinprick, tuning forks, and temperature objects, the doctor maps out areas of reduced feeling; loss of vibration and position sense in the feet and ankles is particularly common in CMT and helps confirm sensory involvement. malacards.org+2Dove Medical Press+2
8. Romberg and balance tests – Standing with feet together and eyes closed, or walking heel-to-toe in a straight line, allows the examiner to see how much balance is affected; a positive Romberg (falling when eyes are closed) is typical of loss of joint-position sense from large-fiber neuropathy. Wiley Online Library+2Dove Medical Press+2
9. Formal visual acuity and color vision tests – Eye charts and color plates check how clearly the patient sees and how well they distinguish colors; reduced central vision and color vision are common consequences of optic neuropathy in CMTX5 and support the diagnosis. malacards.org+2chorobyrzadkie.gov.pl+2
10. Formal audiology (pure-tone and speech audiometry) – Hearing specialists measure hearing thresholds across frequencies and how well the patient understands speech; the finding of bilateral, profound, sensorineural hearing loss beginning in early life matches the typical hearing profile in CMTX5. ScienceDirect+2malacards.org+2
Laboratory and Pathological
11. Targeted PRPS1 genetic testing – The most important confirmatory test is DNA analysis of the PRPS1 gene, usually from a blood sample; finding a pathogenic loss-of-function PRPS1 mutation confirms the diagnosis of CMTX5 and helps with family counseling and carrier detection. malacards.org+2NCBI+2
12. Multigene CMT or neuropathy panels – In many centers, broad genetic panels that include many neuropathy and hearing-loss genes are used; when the panel detects a PRPS1 variant that matches the patient’s symptoms, the diagnosis is made even if CMTX5 was not suspected initially. malacards.org+2malacards.org+2
13. Whole-exome or genome sequencing – For complex or unclear cases, exome or genome sequencing can identify new or rare PRPS1 variants, as shown in published families where exome sequencing discovered novel CMTX5 mutations when other tests were negative. PMC+2JCN+2
14. Basic blood tests to exclude other neuropathies – Tests such as blood sugar, vitamin B12, thyroid function, kidney and liver function, and autoimmune markers are often done; although they do not diagnose CMTX5, normal results help rule out more common acquired causes of neuropathy and support the hereditary diagnosis. Wiley Online Library+2Dove Medical Press+2
15. Nerve biopsy (rarely used now) – In the past, a small piece of nerve was sometimes removed and examined under a microscope to show chronic axonal degeneration and possible secondary demyelination; today, because genetic testing is widely available, nerve biopsy is used less often but can show typical features of hereditary neuropathy when performed. malacards.org+2Dove Medical Press+2
Electrodiagnostic
16. Nerve conduction studies (NCS) – This test uses small electrical pulses to measure how quickly and strongly nerves conduct signals; in CMTX5, NCS usually show chronic axonal neuropathy with reduced amplitudes (weak responses) and sometimes mildly slowed conduction, supporting diagnosis of a hereditary sensorimotor neuropathy. malacards.org+2Dove Medical Press+2
17. Electromyography (EMG) – A thin needle electrode records the electrical activity of muscles; in CMTX5, EMG typically shows chronic denervation and re-innervation patterns, confirming that muscle weakness is due to nerve damage rather than a primary muscle disease. malacards.org+2Dove Medical Press+2
18. Brainstem auditory evoked potentials (BAEPs) – This test measures how the brainstem responds to sound; in CMTX5, BAEPs often show reduced or absent waves in keeping with severe sensorineural hearing loss and auditory nerve involvement, adding objective evidence of the hearing pathway damage. ScienceDirect+2malacards.org+2
19. Visual evoked potentials (VEPs) – VEPs record the brain’s electrical response to visual patterns; delayed or reduced responses are common in optic neuropathies and help detect early optic nerve involvement in CMTX5 even before severe visual loss appears. malacards.org+2chorobyrzadkie.gov.pl+2
20. Electroretinography (ERG) in selected cases – ERG measures the function of the retina itself; in CMTX5, the retina is usually less affected than the optic nerve, so ERG may be relatively normal while VEPs are abnormal, which supports the diagnosis of a primarily optic nerve problem. malacards.org+2chorobyrzadkie.gov.pl+2
Imaging
21. Optical coherence tomography (OCT) – OCT uses light waves to take very detailed cross-section pictures of the retina and optic nerve head; in CMTX5, OCT typically shows thinning of the retinal nerve fiber layer, confirming structural loss of optic nerve fibers over time. malacards.org+2chorobyrzadkie.gov.pl+2
22. MRI of the brain and optic pathways – Magnetic resonance imaging can show thinning of the optic nerves and sometimes mild cerebellar atrophy in PRPS1-related disease; MRI also helps exclude other causes of vision or balance problems, such as tumors or inflammatory lesions. ScienceDirect+2PMC+2
23. CT or MRI of the temporal bones (inner ears) – Imaging of the inner ears and auditory canals can rule out structural causes of deafness and support the diagnosis of a neuropathic or cochlear problem rather than a malformation; this is especially helpful when deciding on cochlear implant surgery. ScienceDirect+2Global Genes+2
24. X-rays of the feet and spine – Simple X-rays can show pes cavus deformities, claw toes, and scoliosis, documenting the skeletal consequences of long-standing neuropathy and helping orthopedic planning for braces, surgery, or other supportive care. malacards.org+2Wiley Online Library+2
25. Ultrasound or MRI of peripheral nerves (research or complex cases) – In some studies, imaging of peripheral nerves can show their size and structure and may help differentiate hereditary neuropathies from inflammatory ones, although this is not yet a standard test for CMTX5. Dove Medical Press+2malacards.org+2
Non-Pharmacological Treatments ( Therapies and Other Approaches)
-
Individualized physical therapy and stretching
Regular physical therapy with gentle stretching is one of the most important non-drug treatments for CMTX5. It helps keep joints flexible, reduces muscle tightness, and slows down the development of contractures (stiff, fixed joints). Physiotherapists can design safe programs with low-impact exercises such as cycling or swimming, which improve strength and endurance without over-tiring weak muscles.MDPI+3Physiopedia+3Mayo Clinic+3 -
Strength and balance training
Targeted strength training for remaining healthy muscles, together with balance exercises, can improve walking, reduce falls, and maintain independence in daily activities. Therapists usually use light resistance, repeated many times, and balance tasks like standing on different surfaces or walking along a line. These exercises must be supervised early on, especially in children, to avoid over-work of already weak muscles.PMC+2Charcot-Marie-Tooth Disease+2 -
Ankle-foot orthoses (AFOs) and other braces
Braces such as ankle-foot orthoses support weak ankles and help lift the foot during walking (foot drop). This makes walking safer and less tiring. Good orthoses can correct or slow worsening of pes cavus (high-arched feet) and improve overall posture. An experienced orthotist will adjust brace type and stiffness according to the severity of CMTX5.Pod NMD+3Charcot-Marie-Tooth Association+3nhs.uk+3 -
Custom footwear and insoles
Special shoes with wide toe boxes, soft uppers, and custom insoles can reduce pressure points, prevent ulcers, and improve foot alignment. For people with high arches or claw toes, podiatry and footwear adjustments help distribute body weight more evenly, which reduces pain and helps walking efficiency.ScienceDirect+1 -
Occupational therapy for hand and daily-living skills
Occupational therapists teach practical strategies and provide devices to make daily activities easier, such as adapted cutlery, button hooks, writing aids, and computer modifications. For CMTX5, where hand weakness and sensory loss can progress, early occupational therapy can preserve independence in self-care, school, and work.PMC+2SOAR+2 -
Hearing rehabilitation and hearing aids
CMTX5 often includes early sensorineural hearing loss. Audiologists can fit digital hearing aids that amplify sounds and improve speech understanding. Early fitting helps language development in children and supports communication and learning in adults. Hearing therapy may also include lip-reading skills and environmental modifications to reduce background noise.PMC+2JCN+2 -
Cochlear implantation (in selected cases)
In some people, hearing loss becomes too severe for hearing aids. In those cases, cochlear implant surgery may be considered. This device bypasses damaged inner ear cells and directly stimulates the hearing nerve. For CMTX5, cochlear implants may improve hearing, but careful testing and counseling by a specialized team are required.ScienceDirect+1 -
Low-vision aids and visual rehabilitation
Optic atrophy in CMTX5 can cause reduced clarity of vision and problems with reading. Low-vision specialists can provide magnifiers, high-contrast reading material, special lighting, and electronic reading devices. Training in these tools helps people continue school, work, and hobbies despite visual limitations.PMC+2Wiley Online Library+2 -
Assistive walking devices (canes, crutches, walkers)
As leg weakness and balance problems progress, simple devices such as canes, crutches, or rolling walkers can greatly improve stability and confidence. They reduce the risk of falls and allow people to walk longer distances safely. The type of device depends on strength, balance, and lifestyle, and should be chosen with a physical therapist.ScienceDirect+1 -
Wheelchairs and mobility scooters
Some individuals with CMTX5 may eventually need a manual or power wheelchair for long distances or full-time use. Modern chairs can be customized for posture support and pressure relief. Using a wheelchair is not a sign of “giving up”; it is a tool to preserve energy, participate in school or work, and maintain social life.PMC+1 -
Hydrotherapy and aquatic exercise
Exercise in warm water can be very helpful in CMTX5. Water supports the body weight, making it easier to move weak muscles without stress on joints. Swimming or guided pool exercise improves cardiovascular fitness, flexibility, and mood, and is usually well tolerated even with significant weakness.Physiopedia+2PMC+2 -
Night splints and stretching braces
Night splints for ankles or toes are soft or rigid devices worn while sleeping. They hold joints in a position that reduces the risk of contractures and morning stiffness. In CMTX5, night splints are often combined with daytime AFOs and regular stretching exercises to maintain the best possible alignment of the feet and ankles.PMC+1 -
Pain psychology and cognitive-behavioral therapy (CBT)
Chronic neuropathic pain can strongly affect mood, sleep, and coping. Psychological approaches like CBT teach skills to manage pain signals, reduce anxiety, and improve function. These methods do not remove the nerve damage, but they help the brain handle pain in a healthier way and can work together with medications.PMC+1 -
Mental health support and counseling
Living with a rare, progressive condition can cause stress, sadness, or depression. Counseling, peer support groups, and family therapy can help people talk about fears, plan for the future, and find emotional strength. Stable mental health improves quality of life and makes it easier to follow exercise and treatment plans.PMC+2Muscular Dystrophy Association+2 -
Genetic counseling for families
Because CMTX5 is inherited, genetic counselors explain the pattern of inheritance, recurrence risk in future pregnancies, and options for testing family members. They help relatives understand carrier status and support informed decisions about family planning. This is especially important in X-linked conditions, where mothers may be carriers.ZFIN+2Monarch Initiative+2 -
Education and vocational rehabilitation
School and work may need adjustments to fit reduced mobility or vision and hearing problems. Vocational rehabilitation services can suggest modified duties, ergonomic equipment, flexible schedules, and training for new roles. Early planning helps young people with CMTX5 choose careers that suit their abilities and health.nhs.uk+2SOAR+2 -
Home safety modifications
Simple changes at home—such as removing loose rugs, adding grab bars in the bathroom, using non-slip mats, and improving lighting—can significantly reduce fall risk. Stair rails, ramps, and adapted kitchen layouts help people move safely and stay independent as mobility changes over time.Mayo Clinic+1 -
Spinal cord or peripheral nerve stimulation for pain (advanced centers)
In some patients with severe, resistant neuropathic pain, advanced pain clinics may consider neurostimulation techniques, such as spinal cord stimulation. These devices deliver small electrical pulses to the nervous system to reduce pain signals. Evidence is still evolving, and this is reserved for adults with severe pain after other treatments fail.Wikipedia+1 -
Community and patient-support organizations
Charcot-Marie-Tooth support groups and foundations provide education materials, newsletters, webinars, and local meetings. They connect families facing similar challenges, share practical tips, and may help find clinical trials. Being part of a community can reduce isolation and improve emotional well-being.Charcot-Marie-Tooth Association+2Muscular Dystrophy Association+2 -
Regular long-term follow-up with a multidisciplinary clinic
The most important non-drug “treatment” is continuous follow-up with a team that understands CMT. Regular visits help adjust braces, change exercise plans, review vision and hearing, manage pain, and detect treatable complications early. This team approach is now the standard recommendation for Charcot-Marie-Tooth diseases.PMC+2ScienceDirect+2
Drug Treatments
There is no drug that can cure or directly reverse Charcot-Marie-Tooth neuropathy X-linked recessive 5. The medicines below are used to treat symptoms such as neuropathic pain, cramps, depression, sleep problems, and other issues. Many are approved by the U.S. FDA for other neuropathic pain conditions (for example, diabetic peripheral neuropathic pain or postherpetic neuralgia) and may be used off-label in CMT after careful medical judgment.
-
Pregabalin
Pregabalin is an anticonvulsant that calms overactive nerve cells by binding to calcium channels. The FDA has approved pregabalin for several neuropathic pain conditions, including diabetic peripheral neuropathy and postherpetic neuralgia, usually starting around 150 mg per day and increasing based on response and kidney function. Common side effects are dizziness, sleepiness, weight gain, and swelling. In CMTX5, doctors may use pregabalin to reduce burning or shooting neuropathic pain.NCBI+3FDA Access Data+3FDA Access Data+3 -
Gabapentin
Gabapentin is another anticonvulsant used widely for neuropathic pain. FDA labeling for gabapentin (for example, Neurontin and Gralise) includes postherpetic neuralgia, with adult doses typically built up from about 900 mg per day to higher doses as tolerated. Side effects include drowsiness, dizziness, and swelling of legs. In CMTX5, gabapentin may reduce nerve pain and improve sleep, but must be adjusted for kidney function.FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Duloxetine
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant approved by the FDA for diabetic peripheral neuropathic pain and fibromyalgia at doses around 60 mg per day. It changes brain chemicals that handle pain signals and mood. Common side effects are nausea, dry mouth, sleepiness, or sweating. In a person with CMTX5 and painful neuropathy plus low mood, duloxetine can treat both conditions at once under medical supervision.FDA Access Data+4FDA Access Data+4FDA Access Data+4 -
Amitriptyline
Amitriptyline is a tricyclic antidepressant often used at low doses at night for neuropathic pain and sleep. It works by increasing serotonin and norepinephrine in the brain and affecting sodium channels in nerves. Side effects include dry mouth, constipation, drowsiness, and sometimes heart rhythm issues, so heart history and other medicines must be checked before using it in CMTX5. -
Nortriptyline
Nortriptyline is related to amitriptyline but is sometimes better tolerated, with slightly fewer sedating and anticholinergic effects. Doctors may choose it for neuropathic pain in patients who cannot handle amitriptyline. Dosing is usually low at first and slowly increased. It can help nerve pain and improve sleep quality but must be used carefully in older adults and in people with heart disease. -
Topical lidocaine 5% patches
Lidocaine patches provide local numbing of painful skin areas. The FDA has approved lidocaine 5% patches for postherpetic neuralgia, and they are often used off-label on other focal neuropathic pain spots. The patch is placed on intact skin for a limited number of hours per day to avoid systemic toxicity. In CMTX5, patches may relieve pain in specific areas, such as part of a foot. -
Topical capsaicin (high-strength patch or cream)
Capsaicin, an extract from chili peppers, depletes a pain messenger called substance P from nerve endings. High-strength 8% capsaicin patches (Qutenza) are FDA-approved for neuropathic pain, and lower-strength creams are available. Application can cause strong burning at first, so it is usually done under medical supervision. In CMTX5, capsaicin can sometimes reduce localized burning pain. -
Non-steroidal anti-inflammatory drugs (NSAIDs)
Drugs like ibuprofen or naproxen are not specific for neuropathic pain, but they can help with muscle and joint pain, especially in people with foot deformities or over-use. They work by blocking cyclo-oxygenase enzymes and reducing prostaglandins, which drive inflammation. Long-term use can affect the stomach, kidneys, and heart, so they should be used at the lowest effective dose and only with doctor guidance. -
Paracetamol (acetaminophen)
Paracetamol is used worldwide for mild to moderate pain. It works differently from NSAIDs and does not reduce inflammation, but it can ease background pain and headaches. It is usually safe at recommended doses, but high doses can damage the liver. In CMTX5 it may be combined with other treatments as a simple pain reliever, especially in children under specialist care. -
Baclofen
Baclofen is a muscle relaxant that acts on GABA-B receptors in the spinal cord to reduce muscle spasticity and cramps. Some people with neuropathies develop painful spasms that can be helped by baclofen. Common side effects are sleepiness and weakness, so doses must be increased slowly. Sudden stopping after long use can cause withdrawal symptoms, so any change must be supervised by a doctor. -
Tizanidine
Tizanidine is another muscle relaxant used for spasticity. It works mainly through alpha-2 adrenergic receptors, reducing nerve signals to muscles. It can help night-time muscle cramps or stiffness in some neuropathy patients. Side effects include low blood pressure, dry mouth, and drowsiness, and liver tests may be needed. -
Clonazepam (for severe cramps or tremor)
Clonazepam is a benzodiazepine that enhances GABA signaling and can calm severe muscle cramps, tremors, or anxiety. It must be used carefully because of sedation, risk of dependence, and breathing depression, especially if combined with other sedating medicines. In CMTX5 it may be reserved for short-term use when other methods fail. -
Sertraline or other SSRI antidepressants
Depression and anxiety are common in many chronic neurological diseases. Selective serotonin reuptake inhibitors like sertraline can improve mood, sleep, and coping. They do not directly treat neuropathic pain, but better mood often makes pain easier to manage. Doctors choose specific SSRIs depending on age, other drugs, and side-effect profile. -
Melatonin for sleep regulation
Melatonin is a hormone that helps regulate the sleep–wake cycle. In people with CMTX5 who have pain-related insomnia or irregular sleep schedules, low-dose melatonin may help re-set sleep timing. It is usually taken before bedtime and is generally well tolerated, but timing and dose should still be discussed with a clinician. -
Vitamin B12 injections (if deficiency is present)
Vitamin B12 deficiency can worsen neuropathy. If blood tests show low B12, doctors may give injections to refill body stores. This does not cure CMTX5 but prevents additional nerve damage from deficiency. Side effects are usually mild, such as injection-site discomfort. Self-supplementation without testing is not recommended because very high doses are not always harmless. -
Folic acid and general multivitamins (if deficient)
If laboratory tests show low folate or other vitamin deficiencies, correcting them with supplements can support overall nerve health. This is especially important in people with poor appetite or restricted diets. Supplementation should be guided by blood test results so that doses are appropriate and safe. -
Pain-modulating SNRIs other than duloxetine (for example, venlafaxine)
Other SNRIs such as venlafaxine may be considered for neuropathic pain when duloxetine is not tolerated. They also act on serotonin and norepinephrine pathways and can improve both mood and pain. Dosing needs slow titration to avoid side effects like blood pressure changes, nausea, or sweating. -
Tramadol (short-term use in selected adults)
Tramadol is a weak opioid with additional SNRI-like effects. It may be used short-term for moderate to severe pain that does not respond to other treatments. However, it has risks of dependence, dizziness, constipation, and breathing problems, so it must be used cautiously and is generally avoided in children and young people unless a pain specialist is involved. -
Topical emollients and skin-care products
Although not “drugs” in the narrow sense, medicated creams and emollients help protect fragile skin on numb feet, preventing cracks and infections. Doctors may prescribe antimicrobial or urea-based creams for particular problems. Good skin care reduces complications that could further limit mobility. -
Avoidance of nerve-toxic drugs (for example, vincristine)
An important “treatment” is to avoid medicines known to damage peripheral nerves, such as some chemotherapy agents like vincristine. These drugs can dramatically worsen neuropathy and are generally listed as “do not use” in people with CMT whenever possible. If such drugs are absolutely necessary, a neurologist should be involved and nerve function monitored closely.Wikipedia+1
Dietary Molecular Supplements
-
Alpha-lipoic acid – An antioxidant that may support nerve metabolism and reduce oxidative stress seen in neuropathies.
-
Coenzyme Q10 – Helps in mitochondrial energy production; sometimes used to support muscle and nerve energy.
-
Omega-3 fatty acids (EPA/DHA) – Anti-inflammatory fats from fish oil that may support heart, brain, and nerve health.
-
Vitamin D – Important for bone and muscle strength; deficiency is common in people with reduced mobility and should be corrected based on blood levels.
-
Vitamin B-complex – B1, B6, and B12 are important for nerve function; balanced doses may support general nerve health when deficiency is present.
-
Magnesium – Can help with muscle cramps in some people; too much can cause diarrhea or kidney strain, so dosing must be cautious.
-
Acetyl-L-carnitine – An amino-acid-like compound studied in some neuropathies; thought to support mitochondrial function and nerve repair.
-
Curcumin (turmeric extract) – Has anti-inflammatory and antioxidant actions; may support general joint comfort when combined with a healthy diet.
-
Resveratrol and polyphenol mixtures – Plant-based antioxidants sometimes marketed for nerve and brain health; evidence in CMTX5 is limited, so they must not replace proven care.
-
Probiotics – Support gut health and may indirectly help inflammation and nutrient absorption, especially when long-term medications are used.
For all supplements, exact dose, timing, and interactions with prescription drugs must be checked by a doctor or clinical dietitian. High doses are not always better and can sometimes be harmful.
Immunity-Boosting and Regenerative / Stem-Cell-Related Drugs
-
Standard vaccines (not an experimental drug but crucial)
Up-to-date vaccines (influenza, COVID-19, pneumococcal, etc.) are a simple way to “boost” the immune system’s protection. Avoiding serious infections helps prevent hospital stays and loss of mobility, which are especially harmful in CMTX5. Vaccine schedules should follow national guidelines and any special advice from the neurologist. -
Intravenous immunoglobulin (IVIG) – limited role
IVIG is a pooled antibody product used for many autoimmune neuropathies. CMTX5 is not autoimmune, so IVIG is not standard therapy, but sometimes it may be used if there is diagnostic uncertainty or overlapping immune disease. It modulates the immune system in complex ways and must be given in hospital with careful monitoring. -
Experimental gene therapy approaches
Research is exploring gene therapies that could correct or compensate for genetic defects in some neuropathies. For PRPS1-related CMTX5, this might include viral vectors that provide a working copy of the gene or adjust its expression. These approaches are still at the laboratory or early-trial stage and are not part of routine care, but patients may hear about them in clinical-trial discussions.Wiley Online Library+2Wiley Online Library+2 -
Neurotrophic factor-based drugs (research)
Neurotrophic factors are proteins that support neuron survival and repair. Experimental drugs delivering or mimicking such factors are being studied in several hereditary neuropathies. They aim to protect nerves from degeneration or encourage regrowth, but none are yet approved for CMTX5, and use is limited to clinical trials.ScienceDirect+1 -
Cell-based regenerative therapies (experimental)
Some research programs are looking at stem-cell-based treatments for peripheral nerve injuries, using mesenchymal or neural stem cells to support regeneration. For inherited neuropathies like CMTX5, the challenge is that the genetic problem remains in the body, so cell therapy is complex and still experimental. Any offer of “stem cell cure” outside controlled trials should be approached with great caution.ScienceDirect+1 -
Future small-molecule modulators of PRPS1 pathways
Because CMTX5 is linked to PRPS1 enzyme dysfunction, scientists are exploring small molecules that might stabilize the enzyme or adjust related metabolic pathways. These are still theoretical or in very early development. At present, no such medicine is available clinically, but this is an area to watch in future research updates.Wiley Online Library+3PMC+3JCN+3
Surgical Treatments ( Procedures and Why They Are Done)
-
Soft-tissue surgery for foot deformity
When high-arched feet and claw toes become severe, surgeons may release tight tendons and ligaments to improve foot shape and balance. This can reduce pain, make bracing easier, and improve walking. Surgery is usually combined with continued physiotherapy and orthotic support.Wikipedia+1 -
Bony foot reconstruction and osteotomy
If deformities are rigid, the bones of the foot may need to be cut and repositioned (osteotomy). This is more invasive but can provide a more stable weight-bearing surface. The goal is to reduce falls, prevent ulcers, and help the person fit into normal shoes or braces. Recovery requires careful rehabilitation.Wikipedia+1 -
Arthrodesis (joint fusion) for severe instability
In some cases, fusing certain joints in the foot or ankle provides better long-term stability and reduces painful abnormal movement. After fusion, the joint no longer moves, but overall walking can actually become smoother and less painful. Surgeons consider this only when conservative options have failed.Wikipedia+1 -
Cochlear implant surgery for profound hearing loss
For people with CMTX5 whose hearing is no longer helped by hearing aids, cochlear implantation may be offered. In this surgery, an electrode array is placed inside the cochlea, and an external processor sends sound information directly to the hearing nerve. It can greatly improve hearing and communication in selected patients after detailed testing.ScienceDirect+1 -
Spinal surgery (if scoliosis or severe deformity occurs)
CMT may sometimes be associated with scoliosis or other spinal deformities. If curves progress and cause pain, breathing problems, or major imbalance, spinal surgeons may recommend corrective surgery with rods and screws. This is major surgery and is only done when clearly needed, after weighing benefits and risks.Wikipedia+1
Prevention and Lifestyle Strategies
-
Protect feet every day with proper shoes, socks, and skin checks to avoid wounds and infections.
-
Keep moving with safe, regular exercise to maintain strength, flexibility, and heart health.
-
Avoid obesity by following a balanced diet, because extra weight increases stress on weak muscles and joints.
-
Do not smoke or vape, as nicotine and smoke reduce blood flow to nerves and can worsen neuropathy.
-
Limit alcohol, which can damage nerves and interact with many medicines.
-
Manage other health problems such as diabetes, high blood pressure, and vitamin deficiencies, since they can add extra nerve damage on top of CMTX5.
-
Learn about and avoid known nerve-toxic medications when possible, in consultation with doctors.Wikipedia+1
-
Use home safety measures to prevent falls, such as good lighting, rails, and non-slip floors.
-
Keep regular follow-up appointments, even if symptoms feel stable, so that braces, exercises, and medicines can be updated in time.
-
Stay connected to support groups and mental-health resources to prevent isolation and depression.
When to See Doctors
People with Charcot-Marie-Tooth neuropathy X-linked recessive 5 should have regular, planned visits with a neurologist and rehabilitation team, often once or twice a year. You should seek medical help sooner if there is a sudden change in walking, new frequent falls, fast-worsening weakness, or loss of hand function. Any rapid change in vision or hearing, such as sudden blurry vision, eye pain, or strong change in hearing, is an emergency and needs urgent eye or ear specialist review.
New severe pain, especially if it is different from “usual” neuropathic pain, should be checked, because it might be due to fractures, joint problems, or other disease. Signs of depression, anxiety, or thoughts of hopelessness also need prompt support from health-care professionals. Finally, before starting any new prescription drug, over-the-counter medicine, or high-dose supplement, it is wise to ask a doctor or pharmacist who knows about CMT.
What to Eat and What to Avoid
-
Eat plenty of colorful vegetables and fruits every day to provide vitamins, minerals, and antioxidants that support general nerve and muscle health.
-
Include lean protein such as fish, eggs, beans, and pulses to help maintain muscle strength and repair.
-
Choose healthy fats, especially omega-3-rich foods like oily fish, flaxseed, and walnuts, to support heart and nerve health.
-
Use whole grains (brown rice, whole-wheat bread, oats) rather than refined grains to keep energy steady and support a healthy weight.
-
Drink enough water through the day to stay hydrated, especially when exercising or taking medicines that can affect the kidneys.
-
Avoid high-sugar drinks and snacks, which can promote weight gain and, over time, increase the risk of diabetes and extra nerve damage.
-
Limit very salty, highly processed foods, which can worsen blood pressure and swelling.
-
Avoid heavy alcohol use, which is toxic to nerves and can interact with many neuropathic pain medicines.
-
Be careful with extreme diets or self-prescribed mega-doses of supplements, as they can cause deficiencies or toxicity.
-
If appetite is poor or weight is changing quickly, see a doctor or dietitian for a personalized meal plan rather than trying to manage alone.
Frequently Asked Questions
-
Is there a cure for Charcot-Marie-Tooth neuropathy X-linked recessive 5?
No cure exists at present. Treatment focuses on rehabilitation, braces, and symptom-based medicines. Research on gene therapy and other advanced treatments is ongoing, but these are not yet available in routine clinical practice.ScienceDirect+2www.elsevier.com+2 -
How is CMTX5 different from other types of Charcot-Marie-Tooth disease?
CMTX5 is specifically linked to mutations in the PRPS1 gene on the X chromosome and often includes a triad of peripheral neuropathy, early-onset hearing loss, and optic atrophy. Many other CMT types do not affect vision or hearing in the same way and follow different inheritance patterns.NCBI+2ZFIN+2 -
At what age do symptoms usually start?
Symptoms of CMTX5 often begin in childhood or adolescence with delayed motor milestones, frequent tripping, difficulty running, or early hearing problems. Vision problems may appear later. However, age of onset can vary between families and even among brothers.PMC+2JCN+2 -
Can exercise make CMTX5 worse?
Properly planned, low-impact exercise usually helps rather than harms. Over-exertion of very weak muscles can cause excessive fatigue or injury, but guided physiotherapy focusing on endurance, balance, and gentle strength is considered beneficial. Always follow a program designed by a therapist familiar with neuropathies.Physiopedia+2PMC+2 -
Will everyone with CMTX5 need a wheelchair?
Not everyone will need a wheelchair full-time. Some people may use one only for long distances or later in life. The aim is to maintain walking as long as safe, but a wheelchair can be a helpful tool to save energy, prevent falls, and stay active outside the home.PMC+2SOAR+2 -
Can diet alone treat CMTX5?
Diet cannot cure the genetic cause of CMTX5, but a balanced diet can support muscle and nerve health, maintain a healthy weight, and reduce other risk factors like diabetes and heart disease. Supplements should be seen as supportive, not as replacements for medical care. -
Are pain medicines safe for long-term use?
Some pain medicines, like pregabalin, duloxetine, and gabapentin, are commonly used long term under medical supervision. Regular review is needed to adjust doses, monitor side effects, and confirm that benefits still outweigh risks. Strong opioids are usually avoided or used only briefly because of dependence and other serious risks.FDA Access Data+2NCBI+2 -
Can CMTX5 affect breathing or heart function?
Most information on CMTX5 describes limb neuropathy, hearing loss, and optic atrophy. In many CMT types, breathing and heart problems are less common than in some other neuromuscular diseases, but severe scoliosis or advanced weakness can still strain breathing over time. Regular clinical review helps detect any such issues early.PMC+2ScienceDirect+2 -
Is pregnancy safe for women who carry CMTX5?
Many carriers have uncomplicated pregnancies, but they should discuss risks with both a neurologist and an obstetrician. There may be a chance of having an affected son or carrier daughter. Genetic counseling is strongly recommended before pregnancy to understand options such as prenatal or preimplantation testing.ZFIN+2PMC+2 -
Can children with CMTX5 attend normal school?
Yes. Most children with CMTX5 can attend mainstream school with appropriate support, such as physical therapy, hearing aids or cochlear implants, low-vision aids, and extra time for walking between classes. Teachers should be informed about the condition so they can provide suitable accommodations. -
Are there special shoes or devices that help most?
Many patients benefit from ankle-foot orthoses, custom insoles, and supportive shoes with good ankle support and non-slip soles. The exact combination depends on foot shape, strength, and comfort, and should be decided with an orthotist and physiotherapist.Charcot-Marie-Tooth Association+2nhs.uk+2 -
Should people with CMTX5 avoid all sports?
They do not need to avoid all sports. Low-impact activities like swimming, cycling, and water aerobics are usually encouraged. High-impact or contact sports that greatly increase the risk of falls and injuries may not be safe. The best plan is an individualized activity program developed with health-care professionals.Mayo Clinic+2Physiopedia+2 -
How often should hearing and vision be checked?
Because CMTX5 can involve progressive hearing loss and optic atrophy, regular hearing and eye exams are important, often yearly or as recommended by specialists. Early detection of changes allows timely adjustment of hearing aids, consideration of cochlear implants, and optimal use of low-vision aids.PMC+2ScienceDirect+2 -
Can people with CMTX5 work as adults?
Yes. Many adults with CMT and related conditions work successfully in a wide range of jobs. Early vocational guidance helps people choose careers that are less physically demanding or that allow adaptive equipment and flexible schedules. Workplace modifications can often be arranged under disability and employment laws.nhs.uk+2SOAR+2 -
Where can families find reliable information and support?
Families can look for national or international CMT organizations, neuromuscular disease associations, and reputable hospital or university websites. These sources provide updated information, research news, and links to clinical trials and support networks. Always be cautious with unverified online claims, especially those promising “cures” without scientific evidence.ScienceDirect+3Charcot-Marie-Tooth Association+3Muscular Dystrophy Association+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 31, 2025.